Open-label pilot study of quetiapine treatment for cannabis dependence.
about
The cannabis withdrawal syndrome: current insightsIntentional Recreational Abuse of Quetiapine Compared to Other Second-generation Antipsychotics.Interventions to improve lifestyle and quality-of-life in patients with concurrent mental illness and substance use.The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal.
P2860
Open-label pilot study of quetiapine treatment for cannabis dependence.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Open-label pilot study of quetiapine treatment for cannabis dependence.
@ast
Open-label pilot study of quetiapine treatment for cannabis dependence.
@en
Open-label pilot study of quetiapine treatment for cannabis dependence.
@nl
type
label
Open-label pilot study of quetiapine treatment for cannabis dependence.
@ast
Open-label pilot study of quetiapine treatment for cannabis dependence.
@en
Open-label pilot study of quetiapine treatment for cannabis dependence.
@nl
prefLabel
Open-label pilot study of quetiapine treatment for cannabis dependence.
@ast
Open-label pilot study of quetiapine treatment for cannabis dependence.
@en
Open-label pilot study of quetiapine treatment for cannabis dependence.
@nl
P2093
P2860
P1476
Open-label pilot study of quetiapine treatment for cannabis dependence.
@en
P2093
Agnieszka K Mamczur
Edward V Nunes
Frances R Levin
John J Mariani
Martina Pavlicova
P2860
P304
P356
10.3109/00952990.2014.884102
P50
P577
2014-07-01T00:00:00Z